A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target
暂无分享,去创建一个
Dmitri I Svergun | Jörg Eder | Ursula Bodendorf | D. Svergun | A. D'arcy | U. Hassiepen | P. Raman | F. Villard | J. Eder | N. Schiering | Nikolaus Schiering | Allan D'Arcy | Frederic Villard | Oliver Simic | Marion Kamke | Gaby Monnet | Ulrich Hassiepen | Ruth Pulfer | Prakash Raman | M. Kamke | U. Bodendorf | O. Simić | R. Pulfer | Gaby Monnet
[1] M. Murcko,et al. Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide , 1996, Cell.
[2] M. Gale,et al. Evasion of intracellular host defence by hepatitis C virus , 2005, Nature.
[3] M. Katharine Holloway,et al. Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease. , 2008, Journal of the American Chemical Society.
[4] E. Åkerblom,et al. Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3 , 2007, The FEBS journal.
[5] P. Weber,et al. Construction, expression, and characterization of a novel fully activated recombinant single‐chain hepatitis C virus protease , 1998, Protein science : a publication of the Protein Society.
[6] D. Svergun,et al. CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .
[7] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[8] Dmitri I. Svergun,et al. Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .
[9] M. Bolognesi,et al. Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full length NS3 protein. , 2007, Journal of molecular biology.
[10] Ting Xu,et al. Crystal Structure of the NS3 Protease-Helicase from Dengue Virus , 2007, Journal of Virology.
[11] M. Massariol,et al. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A. , 2009, Biochemistry.
[12] A. D'arcy,et al. An automated microseed matrix-screening method for protein crystallization. , 2007, Acta crystallographica. Section D, Biological crystallography.
[13] Andrew S. Kohlway,et al. Unmasking the Active Helicase Conformation of Nonstructural Protein 3 from Hepatitis C Virus , 2011, Journal of Virology.
[14] B. Lee,et al. The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.
[15] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[16] Volker Brass,et al. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex , 2008, Proceedings of the National Academy of Sciences.
[17] P. Bonneau,et al. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. , 2003, Angewandte Chemie.
[18] Dmitri I. Svergun,et al. PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .
[19] I. Melnikova. Hepatitis C — pipeline update , 2011, Nature Reviews Drug Discovery.
[20] S. Zeuzem,et al. A new standard of care for the treatment of chronic HCV infection , 2011, Nature Reviews Gastroenterology &Hepatology.
[21] S. Vasudevan,et al. Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications , 2010, The Journal of Biological Chemistry.
[22] P. Weber,et al. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. , 1999, Structure.
[23] V. Serebrov,et al. The Serine Protease Domain of Hepatitis C Viral NS3 Activates RNA Helicase Activity by Promoting the Binding of RNA Substrate* , 2007, Journal of Biological Chemistry.
[24] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[25] C. Schiffer,et al. Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding , 2010, Proceedings of the National Academy of Sciences.
[26] Susanne Nyström,et al. Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target. , 2010, Angewandte Chemie.
[27] R. Bartenschlager,et al. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation , 1995, Journal of virology.
[28] Todd C Appleby,et al. Visualizing ATP-dependent RNA translocation by the NS3 helicase from HCV. , 2011, Journal of molecular biology.
[29] Markus Kroemer,et al. APRV - a program for automated data processing, refinement and visualization. , 2004, Acta crystallographica. Section D, Biological crystallography.
[30] Dmitri I. Svergun,et al. Upgrade of the small-angle X-ray scattering beamline X33 at the European Molecular Biology Laboratory, Hamburg , 2007 .
[31] E. Mancini,et al. Crystal Structure of a Novel Conformational State of the Flavivirus NS3 Protein: Implications for Polyprotein Processing and Viral Replication , 2009, Journal of Virology.
[32] David I. Stuart,et al. Structure and functionality in flavivirus NS-proteins: Perspectives for drug design , 2010, Antiviral research.
[33] H. Parge,et al. The Crystal Structure of Hepatitis C Virus NS3 Proteinase Reveals a Trypsin-like Fold and a Structural Zinc Binding Site , 1996, Cell.